3/11
08:03 am
artv
Artiva Biotherapeutics (ARTV) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $18.00 price target on the stock.
Medium
Report
Artiva Biotherapeutics (ARTV) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $18.00 price target on the stock.
3/11
06:46 am
artv
Rating for ARTV
High
Report
Rating for ARTV
3/11
06:46 am
artv
Rating for ARTV
High
Report
Rating for ARTV